157 related articles for article (PubMed ID: 28760294)
21. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review.
Oliansky DM; Gordon LI; King J; Laport G; Leonard JP; McLaughlin P; Soiffer RJ; van Besien KW; Werner M; Jones RB; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2010 Apr; 16(4):443-68. PubMed ID: 20114084
[TBL] [Abstract][Full Text] [Related]
22. Successful autologous peripheral blood stem cell transplantation in transformed follicular lymphoma previously treated with radioimmunotherapy (iodine (131)I tositumomab).
Cooney J; Stiff P; Kaminski M
Bone Marrow Transplant; 2002 Mar; 29(6):523-5. PubMed ID: 11960274
[TBL] [Abstract][Full Text] [Related]
23. Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era?
Chaudhary L; Kharfan-Dabaja MA; Hari P; Hamadani M
Bone Marrow Transplant; 2013 Nov; 48(12):1489-96. PubMed ID: 23584438
[TBL] [Abstract][Full Text] [Related]
24. Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experience.
Bourcier J; Gastinne T; Leux C; Moreau A; Bossard C; Mahé B; Blin N; Dubruille V; Touzeau C; Voldoire M; Guillaume T; Peterlin P; Gallas P; Garnier A; Maisonneuve H; Moreau P; Juge-Morineau N; Jardel H; Chevallier P; Moreau P; Le Gouill S
Ann Hematol; 2016 Aug; 95(8):1287-93. PubMed ID: 27297970
[TBL] [Abstract][Full Text] [Related]
25. Advancing radioimmunotherapy and its future role in non-Hodgkin lymphoma.
Reagan PM; Friedberg JW
Future Oncol; 2015; 11(10):1543-53. PubMed ID: 25963431
[TBL] [Abstract][Full Text] [Related]
26. Treatment strategies in follicular lymphomas: current status and future perspectives.
Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Forstpointner R; Nickenig C; Unterhalt M
J Clin Oncol; 2005 Sep; 23(26):6394-9. PubMed ID: 16155025
[TBL] [Abstract][Full Text] [Related]
27. Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy.
Blystad AK; Delabie J; Kvaløy S; Holte H; Vålerhaugen H; Ikonomou I; Kvalheim G
Br J Haematol; 2004 Jun; 125(5):605-12. PubMed ID: 15147376
[TBL] [Abstract][Full Text] [Related]
28. High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.
Hamadani M; Benson DM; Lin TS; Porcu P; Blum KA; Devine SM
Eur J Haematol; 2008 Dec; 81(6):425-31. PubMed ID: 18774954
[TBL] [Abstract][Full Text] [Related]
29. Relapsed/refractory Burkitt lymphoma and HIV infection.
Khan A; Brahim A; Ruiz M; Nagovski N
Int J STD AIDS; 2018 Jun; 29(7):695-703. PubMed ID: 29264956
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index.
Vose JM; Bierman PJ; Loberiza FR; Lynch JC; Bociek GR; Weisenburger DD; Armitage JO
Biol Blood Marrow Transplant; 2008 Jan; 14(1):36-42. PubMed ID: 18158959
[TBL] [Abstract][Full Text] [Related]
31. First-line treatment of follicular lymphoma in the era of monoclonal antibodies.
Coiffier B
Clin Adv Hematol Oncol; 2005 Jun; 3(6):484-91, 505. PubMed ID: 16167027
[TBL] [Abstract][Full Text] [Related]
32. [Early transformation from follicular lymphoma to Burkitt lymphoma].
Takahashi T; Hara T; Yoshikawa T; Shimomura Y; Tsurumi H; Yamada T; Tomita E; Moriwaki H
Rinsho Ketsueki; 2005 Sep; 46(9):1055-9. PubMed ID: 16440764
[TBL] [Abstract][Full Text] [Related]
33. Current controversies in follicular lymphoma.
Aurora V; Winter JN
Blood Rev; 2006 Jul; 20(4):179-200. PubMed ID: 16410034
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy versus autologous stem-cell transplantation for the treatment of transformed follicular lymphoma in the rituximab era.
Tam CS; Herschtal A; Dickinson M; George A; Seymour JF
J Clin Oncol; 2013 Sep; 31(25):3166-7. PubMed ID: 23918946
[No Abstract] [Full Text] [Related]
35. Collection of hematopoietic stem cells after previous radioimmunotherapy is feasible and does not impair engraftment after autologous stem cell transplantation in follicular lymphoma.
Derenzini E; Stefoni V; Maglie R; Casadei B; Pellegrini C; Broccoli A; Stefani G; Fanti S; Motta MR; Narducci R; Argnani L; Zinzani PL
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1695-701. PubMed ID: 24055654
[TBL] [Abstract][Full Text] [Related]
36. [Current treatment of follicular lymphoma].
Bonnet C; Beguin Y; Deprijck B; de Leval L; Fillet G
Rev Med Suisse; 2009 Aug; 5(214):1663-7. PubMed ID: 19772198
[TBL] [Abstract][Full Text] [Related]
37. Follicular lymphoma: 2012 update on diagnosis and management.
Freedman A
Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911
[TBL] [Abstract][Full Text] [Related]
38. Controversies in BMT for lymphoma.
Gascoyne RD; Moskowitz C; Shea TC
Biol Blood Marrow Transplant; 2013 Jan; 19(1 Suppl):S26-32. PubMed ID: 23089568
[TBL] [Abstract][Full Text] [Related]
39. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
40. Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.
Villa D; George A; Seymour JF; Toze CL; Crump M; Lee C; Buckstein R; Stewart DA; MacDonald D; Foley R; Xenocostas A; Sabloff M; Chua N; Couture F; Larouche JF; Cohen S; Savage KJ; Connors JM; Panzarella T; Carney DA; Dickinson M; Kuruvilla J
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1813-8. PubMed ID: 25042735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
